Responsive image
Development Path
Your position:Home > About us > Development Path

2004

On February 19, Ningbo Menovo Pharmaceutical Co.,Ltd. was set up.

On July 13, Anhui Menovo Pharmaceutical Co.,Ltd. was set up.

 

2005

On November 17, Zhejiang Menovo Pharmaceutical Co.,Ltd. was set up.

 

2007

On May 22, Ningbo Lianhua Import & Export Co.,Ltd. was set up.

 

2009

In November, Hongkong United Billion Trade Import And Export Co.,Ltd. was set up.

 

2010

On November 18, Ningbo Menovo Tiankang Pharmaceutical Co.,Ltd. was set up.

 

2012

On April 6, Shanghai New International Pharmaceutical Co.,Ltd. was set up.

On July 31, Hangzhou Sinovo Medicine Co.,Ltd. was set up.

 

2013

On November 8, Menovo R&D Center was set up.

 

2014

On March 18, the company took a stake in Zhejiang Ruibang Pharmaceutical Co.,Ltd.

In April, the company took a stake in Zhejiang Porton Pharmaceutical Co.,Ltd.

 

2015

On May 15, Xuancheng Menovo Pharmaceutical Co.,Ltd. was set up.

In September, Biomenovo Researce Private Limited was set up.

 

2017

On April 7, Menovo listed on Shanghai Stock Exchange.

On November 1, Menovo controlled Zhejiang Liaoyuan Pharmaceutical Co.,Ltd.

On November 15, Ningbo Krka Menovo Pharmaceutical Co.,Ltd. was set up.

 

2018

On April 11, the company signed cooperation agreements with Shanghai Ruihe Asset Management Co.,Ltd and other four companies to participate in the “Ningbo Menovo Ruihe Equity Investment Partnership (limited partnership)”.

 

2020

On March 16, Ningbo Menovo Pharmaceutical Technology Co.,Ltd. was set up.

Responsive image

About us

Responsive image

Products and services

Responsive image

Technology R & D

Responsive image

Quality system

Responsive image

Social responsibility

Pay attention to our
Responsive image